DIAGNOSTIC AND TREATMENT OF BRONCHIAL ASTHMA IN CHILDREN OF PRESCHOOL AGE. PLACE OF NEBULIZED INHALED GLUCOCORTICOSTEROIDS IN TREATMENT OF BRONCHIAL ASTHMA AND CROUP (CONSENSUS ON THE RESULTS OF THE COUNCIL OF EXPERTS OF THE PEDIATRIC RESPIRATORY SOCIETY)

Although bronchial asthma is a widespread disease in pediatric population, physicians still face difficulties in early diagnostics  of bronchial asthma in preschool children due to a high frequency of bronchial obstruction in this age group. This article covers key  points of the resolution adopted by the Panel of Experts of Pediatric Respiratory Society regarding standardization of the approach  to diagnostics and therapy of broncho-obstructive conditions, considering a cause of the disease, child’s age and condition severity,  as well as a place of nebulized budesonide suspension in maintenance treatment of bronchial asthma and acute exacerbations therapy.

1. Global Burden of Disease Study, 2014. http://www.globalasthmareport.org/burden/burden.php

2. Local recommendations: “The National Program of Bronchial Asthma in Children”. Moscow, 2017; 160. (in Russ)

3. GINA Report 2018, Global Strategy for Asthma Management and Prevention. http://ginasthma.org/2018-gina-reportglobal-strategy-for-asthma-management-and-prevention/

4. Papadopoulos N.G., Arakawa H., Carlsen K.H., Custovic A., Gern J., Lemanske R. et al. International consensus on (ICON) pediatric asthma. Allergy 2012; 67(8): 976-997. DOI: 10.1111/j.1398-9995.2012.02865.x

5. Camargo J. Association between common asthma therapies and recurrent asthma exacerbations in children enrolled in a state Medicaid plan. Am J Health Syst Pharm 2007; 64(10): 1054-1061.

6. Selroos O., Lofroos A. B., Rietinalho A. Riska H. Asthma control and steroid doses 5 years after early or delayed introduction of inhaled corticosteroids in asthma: a real-life study. Respir Med 2004; 98: 254-262.

7. Novel inhalation devices for the treatment of respiratory diseases: report of the working group of the European respiratory society and the International society for the use of aerosols in medicine. Pul’monologiya (Pulmonology) 2011; 6: 17-41. (in Russ)

8. Nikander K., Sanders M. The early evolution of nebulizers. Medica Mundi 2010; 54: 47-53.

9. Sheth P., Stein S.W., Myrdal P.B. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers [J]. Int J Pharm, 2013, 455 (1-2):57-65. DOI: 10.1016/j.ijpharm.2013.07.061

10. Michotte J.B., Jossen E., Roeseler J., Liistro G., Reychler G. In vitro comparison of five nebulizers during noninvasive ventilation: analysis of inhaled and lost doses. J Aerosol Med Pulm Drug Deliv 2014; 27(6): 430-440. DOI: 10.1089/jamp.2013.1070

11. Dolovich M.B., Ahrens R.C., Hess D.R., Anderson P., Dhand R., Rau J.L. et al. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005; 127(1): 335-371. DOI: 10.1378/chest.127.1.335

12. Erzinger S., Schueepp K.G., Brooks-Wildhaber J., Devadason S.G., Wildhaber J.H. Facemasks and aerosol delivery in vivo. J Aerosol Med 2007; 20(Suppl 1): S78-S83. DOI: 10.1089/jam.2007.0572

13. Baker J.W., Mellon M., Wald J., Welch M., Cruz-Rivera M., Walton-Bowen K. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants. Pediatrics 1999; 103(2): 414-421.

14. Zaitseva O. V. Novel aspects of maintenance therapy of bronchial asthma in children under 6 years old. Pul’monologiya (Pulmonology) 2014; 5: 94100. (in Russ)

15. Aljebab F., Choonara I., Conroy S. Systematic review of the toxicity of shortcourse oral corticosteroids in children. Arch Dis Child 2016; 101: 365–370. DOI: 10.1136/archdischild-2015-309522.

16. Fernandes R.M., Oleszczuk M., Woods C.R., Rowe B.H., Cates C.J., Hartling L. The Cochrane Library and safety of systemic corticosteroids for acute respiratory conditions in children: an overview of reviews. Evid Based Child Health 2014; 9(3): 733-747. DOI: 10.1002/ebch.1980

17. Richards R.N. Side effects of short-term oral corticosteroids. J Cutan Med Surg 2008; 12(2): 77-81.

18. Agertoft L., Andersen A., Weibull E., Pedersen S. Systemic availability and pharmacokinetics of nebulised budesonide in preschool children. Arch Dis Child 1999; 80(3): 241–247.

19. Hvizdos K.M., Jarvis B. Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disorders. Drugs 2000; 60(5): 1141–1178.

20. Berger W.E. Budesonide Inhalation Suspension for the Treatment of Asthma in Infants and Children. Drugs 2005; 65(14): 1973–1989.

21. Milani G.K., Rosário Filho N.A., Riedi C.A., Figueiredo B.C. Nebulized budesonide to treat acute asthma in children. J Pediatr (Rio J) 2004; 80(2): 106-112.

22. Matthews E.E., Curtis P.D., McLain B.I. Nebulized budesonide versus oral steroid in severe exacerbations of childhood asthma. Acta Paediatr 1999; 88(8): 841-843.

23. Volovitz B. Inhaled budesonide in the management of acute worsenings and exacerbations of asthma: A review of the evidence. Respiratory Medicine 2007; 101: 685–695.

24. Sekerel B.E., Sackesen C., Tuncer A., Adalioglu G. The effect of nebulized budesonide treatment in children with mild to moderate exacerbations of asthma. Acta Paediatr 2005; 94(10): 1372-1377.

25. Croup in children (acute obstructive laryngitis) IDC-10 J 05.0: Clinical recomendations. Moscow, 2016; 32. (in Russ)

26. Bjornson C.L., Johnson D.W. Croup in children. CMAJ 2013; 185: 1317–1323.

27. Cherry J.D. Clinical practice: croup. N Engl J Med 2008; 358: 384-391. DOI: 10.1056/NEJMcp072022.

28. Russell K.F., Liang Y., O’Gorman K., Johnson D.W., Klassen T.P. Glucocorticoids for croup. Cochrane Database Syst Rev 2011; 19(1): CD001955.

29. Toward Optimized Practice. Diagnosis and Management of Croup. Clinical Practice Guideline, 2008; www.topalbertadoctors.org/download/252/croup_guideline.pdf

30. Cetinkaya F., Tufekc B.S., Kutluk G. A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup. Int J Pediatr Otorhinolaryngol 2004; 68:453–456.